John Wiley & Sons Inc. logo

John Wiley & Sons Inc. (2F7)

Market Closed
27 Feb, 07:01
XBER XBER
26. 40
0
0%
2.9B Market Cap
- P/E Ratio
1.4% Div Yield
0 Volume
2.25 Eps
26.4
Previous Close
Day Range
26.4 26.4
Year Range
25.8 43.2
Want to track 2F7 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
WLY earnings report is expected in 1 days (4 Mar 2026)

Summary

2F7 closed Friday higher at €26.4, an increase of 0% from Thursday's close, completing a monthly increase of 0% or €0. Over the past 12 months, 2F7 stock gained 0%.
2F7 pays dividends to its shareholders, with the most recent payment made on Jan 15, 2026. The next estimated payment will be in In 1 month on Apr 15, 2026 for a total of €0.355.
The last earnings report, released on Dec 04, 2025, exceeded the consensus estimates by 0.1%. On average, the company has fell short of earnings expectations by -0.42%, based on the last three reports. The next scheduled earnings report is due on Mar 04, 2026.
John Wiley & Sons Inc. has completed 5 stock splits, with the recent split occurring on Jun 01, 1999.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).

2F7 Chart

Similar

VVU
VIVENDI SE INH. EO 5,5
2.34
0%
6BH
Endeavour Group Limited
2.08
0%
L1N
Link Mobility Group Holding ASA
2.85
0%
9AA
Airtel Africa Plc
4.06
0%
6FE
SIX FLAGS ENTERTAIN.DL-01
13
0%
Are You Looking for a High-Growth Dividend Stock?

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does John Wiley & Sons (WLY) have what it takes?

Zacks | 1 week ago
John Wiley & Sons: Structural Risk To Higher Education Casts A Shadow Over AI Licensing

John Wiley & Sons: Structural Risk To Higher Education Casts A Shadow Over AI Licensing

John Wiley & Sons delivers solid margin improvement and research sales growth, aided by high-margin AI licensing revenues. WLY faces structural headwinds in its learning segment due to weak white-collar job markets and potential long-term enrollment declines from LLM disruption. Despite mixed segment performance, WLY maintains strong FCF generation, robust buybacks, and a combined yield near 13% after recent price declines.

Seekingalpha | 1 week ago
Why John Wiley & Sons (WLY) is a Great Dividend Stock Right Now

Why John Wiley & Sons (WLY) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does John Wiley & Sons (WLY) have what it takes?

Zacks | 3 weeks ago

John Wiley & Sons Inc. (2F7) FAQ

What is the stock price today?

The current price is €26.40.

On which exchange is it traded?

John Wiley & Sons Inc. is listed on XBER.

What is its stock symbol?

The ticker symbol is 2F7.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.4%.

What is its market cap?

As of today, the market cap is 2.9B.

When is the next earnings date?

The next earnings report will release on Mar 04, 2026.

Has John Wiley & Sons Inc. ever had a stock split?

John Wiley & Sons Inc. had 5 splits and the recent split was on Jun 01, 1999.

John Wiley & Sons Inc. Profile

Media Industry
Communication Services Sector
Matthew S. Kissner CEO
XBER Exchange
US9682232064 ISIN
US Country
6,400 Employees
30 Dec 2025 Last Dividend
1 Jun 1999 Last Split
1 Apr 2022 IPO Date

Overview

John Wiley & Sons, Inc., a global research and education company, has been nurturing the world's intellectual and professional communities since 1807. Based in Hoboken, New Jersey, the company thrives through its three operational segments: Research, Academic, and Talent. Serving a diverse array of individuals and organizations—ranging from learned societies and individual researchers to academic, corporate, and government libraries—John Wiley & Sons is recognized for providing scientific, technical, medical, and scholarly journals along with a suite of related content and services. These offerings underscore the company's commitment to supporting the dissemination of knowledge and research across various fields.

Products and Services

John Wiley & Sons, Inc. distinguishes itself by offering a broad spectrum of products and services tailored to meet the needs of the scientific, professional, and educational communities it serves:

  • Scientific, Technical, Medical, and Scholarly Journals: Covering disciplines such as physical sciences and engineering, health sciences, social sciences, and humanities and life sciences, these journals are pivotal in disseminating cutting-edge research to the global scientific community.
  • Literatum Platform: A sophisticated publishing software and service that assists scholarly and professional societies and publishers to effectively deliver, host, enhance, market, and manage their content online, maximizing reach and engagement.
  • Books and Digital Courseware: Ranging from scientific, professional, and education-focused print and digital books to digital courseware, these resources cater to the needs of libraries, corporations, students, professionals, and researchers, facilitating learning and professional development.
  • Test Preparation Services: Offering comprehensive test preparation materials and services that support students and professionals in achieving their academic and career goals.
  • Talent Development Solutions: Dedicated to the professional growth of individuals and organizational success, these services include talent development programs, assessments, and corporate learning solutions designed to cultivate essential skills and competencies.
  • Distribution Channels: John Wiley & Sons leverages a wide array of distribution networks including research libraries, library consortia, independent subscription agents, professional society memberships, bookstores, online booksellers, and direct consumer sales to ensure their products are accessible to a broad audience.

Contact Information

Address: 111 River Street
Phone: 201 748 6000